150 related articles for article (PubMed ID: 3570157)
1. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass.
Gross JB; Reichen J; Zeltner TB; Zimmermann A
Hepatology; 1987; 7(3):457-63. PubMed ID: 3570157
[TBL] [Abstract][Full Text] [Related]
2. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.
Reichen J; Arts B; Schafroth U; Zimmermann A; Zeltner B; Zysset T
Gastroenterology; 1987 Oct; 93(4):719-26. PubMed ID: 3623018
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationship in secondary biliary cirrhosis in the rat. Stereologic and hemodynamic characterization of a model.
Ohara N; Schaffner T; Reichen J
J Hepatol; 1993 Feb; 17(2):155-62. PubMed ID: 8445230
[TBL] [Abstract][Full Text] [Related]
4. Aminopyrine demethylation measured by breath analysis in cirrhosis.
Bircher J; Küpfer A; Gikalov I; Preisig R
Clin Pharmacol Ther; 1976 Oct; 20(4):484-92. PubMed ID: 975720
[TBL] [Abstract][Full Text] [Related]
5. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
Merkel C; Gatta A; Zoli M; Bolognesi M; Angeli P; Iervese T; Marchesini G; Ruol A
Dig Dis Sci; 1991 Sep; 36(9):1197-203. PubMed ID: 1893804
[TBL] [Abstract][Full Text] [Related]
7. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
[TBL] [Abstract][Full Text] [Related]
8. Quantitative testing of liver function in patients with cirrhosis due to chronic hepatitis C to assess disease severity.
Herold C; Heinz R; Radespiel-Tröger M; Schneider HT; Schuppan D; Hahn EG
Liver; 2001 Feb; 21(1):26-30. PubMed ID: 11169069
[TBL] [Abstract][Full Text] [Related]
9. Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis.
Herold C; Ganslmayer M; Deynet C; Hahn EG; Schuppan D
Liver; 2002 Apr; 22(2):159-65. PubMed ID: 12028411
[TBL] [Abstract][Full Text] [Related]
10. [Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass].
Bolognesi M; Merkel C; Angeli P; Caregaro L; Gatta A
Minerva Med; 1988 Dec; 79(12):1035-41. PubMed ID: 3211355
[TBL] [Abstract][Full Text] [Related]
11. 14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease.
Caspary WF; Schäffer J
Digestion; 1978; 17(5):410-8. PubMed ID: 680418
[TBL] [Abstract][Full Text] [Related]
12. The aminopyrine breath test does not correlate with histologic disease severity in patients with cholestasis.
Baker AL; Krager PS; Kotake AN; Schoeller DA
Hepatology; 1987; 7(3):464-7. PubMed ID: 3570158
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of biliary and micronodular cirrhosis on oxidative drug metabolism. In vivo-in vitro correlations of dextromethorphan metabolism in rat models.
Roos FJ; Zysset T; Reichen J
Biochem Pharmacol; 1991 May; 41(10):1513-9. PubMed ID: 2018555
[TBL] [Abstract][Full Text] [Related]
14. Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates.
Merkel C; Morabito A; Sacerdoti D; Bolognesi M; Angeli P; Gatta A
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):276-82. PubMed ID: 9759595
[TBL] [Abstract][Full Text] [Related]
15. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance.
Schnegg M; Lauterburg BH
J Hepatol; 1986; 3(2):164-71. PubMed ID: 3794298
[TBL] [Abstract][Full Text] [Related]
16. Biliary retention in a chronic choledocho-venous fistula in the rat: induction of portal hypertension but not of biliary cirrhosis.
Zimmermann H; Reichen J; Sägesser H; Tenisch B; Zimmermann A
J Hepatol; 1993 Aug; 19(1):110-6. PubMed ID: 8301031
[TBL] [Abstract][Full Text] [Related]
17. The aminopyrine breath test.
Perri F; Pastore M; Annese V; Andriulli A
Ital J Gastroenterol; 1994; 26(6):306-17. PubMed ID: 7949268
[TBL] [Abstract][Full Text] [Related]
18. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
[TBL] [Abstract][Full Text] [Related]
19. Increased hepatic lysosomal activity in biliary cirrhosis originates from hepatocytes rather than from macrophages.
Dufour JF; Zimmermann A; Reichen J
J Hepatol; 1994 Apr; 20(4):524-30. PubMed ID: 8051392
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Van de Casteele M; Roskams T; Van der Elst I; van Pelt JF; Fevery J; Nevens F
Liver Int; 2004 Oct; 24(5):502-9. PubMed ID: 15482349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
